SEARCH

SEARCH BY CITATION

References

  • 1
    Blana A, Murat FJ, Walter B et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol 2008; 53: 11941201
  • 2
    Crouzet S, Rebillard X, Chevallier D et al. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur Urol 2010; 58: 559566
  • 3
    Poissonnier L, Chapelon JY, Rouviere O et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007; 51: 381387
  • 4
    Uchida T, Ohkusa H, Yamashita H et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006; 13: 228233
  • 5
    Warmuth M, Johansson T, Mad P. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer. Eur Urol 2010; 58: 803815
  • 6
    D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003; 21: 21632172
  • 7
    Roach M III, Hanks G, Thames H Jr et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965974
  • 8
    Rebillard X, Soulie M, Chartier-Kastler E et al. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int 2008; 101: 12051213
  • 9
    Heidenreich A, Aus G, Bolla M et al. EAU guidelines on prostate cancer. Actas Urol Esp 2009; 33: 113126
  • 10
    Ganzer R, Rogenhofer S, Walter B et al. PSA nadir is a significant predictor of treatment failure after High-Intensity Focussed Ultrasound (HIFU) treatment of localised prostate cancer. Eur Urol 2008; 53: 547553
  • 11
    Blana A, Brown SC, Chaussy C et al. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int 2009; 104: 10581062
  • 12
    Abdel-Wahab M, Pollack A. Prostate cancer: defining biochemical failure in patients treated with HIFU. Nat Rev Urol 2010; 7: 186187
  • 13
    Fujisue Y, Azuma H, Inamoto T et al. Neoadjuvant hormonal therapy does not impact the treatment success of high-intensity focused ultrasound for the treatment of localized prostate cancer. World J Urol 2011; 29: 689694
  • 14
    Bill-Axelson A, Holmberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011; 364: 17081717
  • 15
    Zelefsky MJ, Eastham JA, Cronin AM et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J Clin Oncol 2010; 28: 15081513
  • 16
    Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60: 311
  • 17
    Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 2008; 112: 307314
  • 18
    Shoji S, Nakano M, Nagata Y, Usui Y, Terachi T, Uchida T. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study. Int J Urol 2010; 17: 715719
  • 19
    Blana A, Hierl J, Rogenhofer S et al. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer. Urology 2008; 71: 863867
  • 20
    Netsch C, Pfeiffer D, Gross AJ. Development of bladder outlet obstruction after a single treatment of prostate cancer with high-intensity focused ultrasound: experience with 226 patients. J Endourol 2010; 24: 13991403